The Management of Gout in Primary Care - Are We Doing it Right?

  • Evelyn Li Ping Lim University of Manchester
  • Timothy Shao Ern Tan Manchester Medical School, The University of Manchester
Keywords: Gout, Management, Allopurinol, Serum uric acid, Primary care

Abstract


Introduction: The soaring incidence of gout in the United Kingdom suggests that medical practitioners should be increasingly aware of optimizing management of gout, which is aimed at pain relief, preservation of joint function and preventing recurrent attacks. Recent guidelines published by the British Society of Rheumatology (BSR), have provided clinicians with a framework for achieving these aims.

Aims: To evaluate the management of gout in a primary care centre in North West England against recognized standards.

Methods: An electronic search on EMIS Web using the Read codes “gout” and “gouty arthritis”, with a specified period of 2010–2013, generated a cohort of patients who were categorized into 2 groups: those prescribed urate-lowering therapy (allopurinol) and those not. Patients on febuxostat were excluded. Clinical data from the patients were extracted and retrospectively audited.

Results: A total of 112 patients were identified, of which only 46% (n = 52) of patients were reviewed after an acute attack. Among those who were prescribed allopurinol, only 19% (n = 12) achieved target serum urate levels while only 67% (n = 42) had their serum urate levels checked regularly and 31% (n = 20) had dosage adjustments. Comparatively, in patients not prescribed allopurinol, a few indications for initiating allopurinol were detected: 29% (n = 12) had more than one attack of gout in a year, 27% (n = 11) suffered from renal insufficiency, 2% (n = 1) presented with tophi, and 17% (n = 7) were on diuretics.

Conclusion: Gout management in this primary care centre is not fully concordant to the BSR guidelines. Clearly, there is a need to improve adherence, particularly in the tight monitoring of serum uric acid levels, medications review, appropriate use of allopurinol, where indicated, and patient follow-up.

Author Biography

Evelyn Li Ping Lim, University of Manchester
Medical Student

References

References

1. Roddy E, Mallen CD, Doherty M. Gout. BMJ. 2013 Oct 1;347:f5648. DOI: http://dx.doi.org/10.1136/bmj.f5648.

2. Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2014 Jan 15. DOI:10.1136/annrheumdis-2013-204463.

3. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;3(8):1582-7.

4. Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther. 2011 Mar 3;13(2):R39. DOI: 10.1186/ar3272.

5. Álvarez-Lario B, Alonso-Valdivielso JL. Gout treatment: when a tablet is not enough. Nat Revs Rheumatol. 2014 Mar;10(3):193 DOI:10.1038/nrrheum.2013.173-c1.

6. Torjesen I. Rates of gout continue to rise in UK, but GP care has not improved. BMJ. 2014 Jan 16;348:g239. DOI: 10.1136/bmj.g239.

7. Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology. 2007 Aug;46(8):1372-4. DOI: 10.1093/rheumatology/kem056a.

8. National Institute for Health and Care Excellence. Gout. National Institute for Health and Care Excellence website. Last revised August 2012. http://cks.nice.org.uk/gout (accessed January 2014).

9. Cottrell E, Crabtree V, Edwards JJ, Roddy E. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract. 2013;14:170. DOI: 10.1186/1471-2296-14-170

10. National Institute for Health and Care Excellence. Febuxostat for the Management of Hyperuricaemia in People with Gout (TA164). London, UK: National Institute for Health and Care Excellence; December 2008.

11. Jordan, Kelsey M. Up-to-date management of gout. Curr Opin Rheumatol. 2012;24(2):145-51. DOI: 10.1097/BOR.0b013e32834ff637.

12. Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010 Jan;6:30-8. DOI:10.1038/nrrheum.2009.236.

13. Perez-Ruiz F. Treating to a target: a strategy to cure gout. Rheumatology. 2009;48 (suppl 2):ii9-14. DOI: 10.1093/rheumatology/kep087.

14. Roberts C, Adebajo A, Long S. Improving the quality of care of musculoskeletal conditions in primary care. Rheumatology. 2002;41:503-8. DOI: 10.1093/rheumatology/41.5.503.
Published
29-Nov-2014
How to Cite
Lim, E., & Tan, T. (2014). The Management of Gout in Primary Care - Are We Doing it Right?. Res Medica, 22(1), 102-110. https://doi.org/10.2218/resmedica.v22i1.822